The clinical trial of CoQ10 for saliva secresion or periodontal disease.
Not Applicable
- Conditions
- Dry mouth
- Registration Number
- JPRN-UMIN000031939
- Lead Sponsor
- Tsurumi University
- Brief Summary
.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 0
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who had a medical history of significant cardiovascular disease, significant pulmonary obstructive disease, gastrointestinal obstructive disease, epilepsy, or Parkinson's disease. Patients currently using drugs known to be xerostomic, taking disease-modifying anti-rheumatic drugs or predonisolone, undergoing radiotherapy for treatment of head and neck cancer.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method saliva secretion, oxidative stress of blood or saliva, saliva CoQ10 determination, Inspection of periodontal tissues.
- Secondary Outcome Measures
Name Time Method